Boudin, Laurys <br/><br/>
[Impact of Her2 and BRCA1/2 status in high-dose chemotherapy and autologous stem cells transplantation in the treatment of breast cancer: The Institut Paoli Calmettes' experience].  [electronic resource] 

 -  Bulletin du cancer  Apr 2017 
 - 332-343 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1769-6917 
<br/><br/><label>Standard No.: </label>10.1016/j.bulcan.2016.12.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Autografts<br/>Breast Neoplasms--drug therapy<br/>Cancer Care Facilities<br/>Carcinoma--drug therapy<br/>Combined Modality Therapy--methods<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Genes, BRCA1<br/>Genes, BRCA2<br/>Genes, erbB-2<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Prognosis<br/>Retrospective Studies<br/>Thiotepa--administration & dosage